Performance of the novel Qiagen artus QS-RGQ viral load assays compared to that of the Abbott RealTime system with genetically diversified HIV and hepatitis C Virus plasma specimens.

@article{Drexler2012PerformanceOT,
  title={Performance of the novel Qiagen artus QS-RGQ viral load assays compared to that of the Abbott RealTime system with genetically diversified HIV and hepatitis C Virus plasma specimens.},
  author={Jan Felix Drexler and Ulrike Reber and Andrea Wuttkopf and Anna Maria Eis-Huebinger and Christian Drosten},
  journal={Journal of clinical microbiology},
  year={2012},
  volume={50 6},
  pages={2114-7}
}
We compared two novel Qiagen QS-RGQ viral load assays with the established Abbott RealTime assays on a highly diversified panel of 121 human immunodeficiency virus (HIV) and 107 hepatitis C virus (HCV) specimens. The quantifications correlated well for all HIV and HCV types, but Qiagen yielded higher HCV concentrations than Abbott, predominantly in genotypes 4 and 5.